Creative Planning’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $245K | Buy |
+16,216
| New | +$283K | ﹤0.01% | 3736 |
|
|
2026
Q1 | – | Sell |
-9,478
| Closed | -$208K | – | 4202 |
|
|
2025
Q4 | $208K | Sell |
9,478
-812
| -8% | -$14.7K | ﹤0.01% | 3510 |
|
|
2025
Q3 | $125K | Buy |
+10,290
| New | +$139K | ﹤0.01% | 3633 |
|
|
2025
Q1 | – | Sell |
-7,582
| Closed | -$273K | – | 3716 |
|
|
2024
Q4 | $273K | Sell |
7,582
-2,958
| -28% | -$100K | ﹤0.01% | 2738 |
|
|
2024
Q3 | $447K | Sell |
10,540
-1,395
| -12% | -$59.1K | ﹤0.01% | 2204 |
|
|
2024
Q2 | $481K | Buy |
11,935
+3,461
| +41% | +$144K | ﹤0.01% | 1973 |
|
|
2024
Q1 | $300K | Buy |
8,474
+670
| +9% | +$18K | ﹤0.01% | 2253 |
|
|
2023
Q4 | $231K | Buy |
7,804
+7,679
| +6,143% | +$159K | ﹤0.01% | 2300 |
|
|
2023
Q3 | $2.6K | Buy |
+125
| New | +$3.43K | ﹤0.01% | 2789 |
|
|
2023
Q2 | – | Sell |
-5,687
| Closed | -$231K | – | 2822 |
|
|
2023
Q1 | $231K | Sell |
5,687
-1,085
| -16% | -$44.9K | ﹤0.01% | 2010 |
|
|
2022
Q4 | $304K | Buy |
6,772
+1,290
| +24% | +$58.4K | ﹤0.01% | 1721 |
|
|
2022
Q3 | $262K | Buy |
5,482
+1,297
| +31% | +$71.1K | ﹤0.01% | 1737 |
|
|
2022
Q2 | $248K | Buy |
4,185
+772
| +23% | +$63.4K | ﹤0.01% | 1737 |
|
|
2022
Q1 | $397K | Buy |
3,413
+405
| +13% | +$47.3K | ﹤0.01% | 1457 |
|
|
2021
Q4 | $453K | Sell |
3,008
-163
| -5% | -$22K | ﹤0.01% | 1374 |
|
|
2021
Q3 | $379K | Hold |
3,171
| – | – | ﹤0.01% | 1453 |
|
|
2021
Q2 | $309K | Buy |
+3,171
| New | +$283K | ﹤0.01% | 1546 |
|
|
2020
Q2 | – | Sell |
-6,379
| Closed | -$410K | – | 2129 |
|
|
2020
Q1 | $410K | Sell |
6,379
-11,150
| -64% | -$781K | ﹤0.01% | 1047 |
|
|
2019
Q4 | $1.04M | Sell |
17,529
-105
| -0.6% | -$6.47K | ﹤0.01% | 773 |
|
|
2019
Q3 | $1.04M | Sell |
17,634
-1,383
| -7% | -$88.3K | ﹤0.01% | 739 |
|
|
2019
Q2 | $1.23M | Buy |
19,017
+735
| +4% | +$47.4K | ﹤0.01% | 685 |
|
|
2019
Q1 | $1.16M | Sell |
18,282
-5,147
| -22% | -$270K | ﹤0.01% | 672 |
|
|
2018
Q4 | $890K | Sell |
23,429
-1,700
| -7% | -$60K | ﹤0.01% | 716 |
|
|
2018
Q3 | $1.08M | Buy |
25,129
+4,129
| +20% | +$144K | ﹤0.01% | 737 |
|
|
2018
Q2 | $462K | Sell |
21,000
-5,000
| -19% | -$61.5K | ﹤0.01% | 1109 |
|
|
2018
Q1 | $129K | Buy |
26,000
+8,000
| +44% | +$25.8K | ﹤0.01% | 1705 |
|
|
2017
Q4 | $42K | Buy |
+18,000
| New | +$56.5K | ﹤0.01% | 1811 |
|
|
2016
Q1 | – | Sell |
-22
| Closed | -$3K | – | 4522 |
|
|
2015
Q4 | $3K | Buy |
22
+20
| +1,000% | +$1.98K | ﹤0.01% | 3933 |
|
|
2015
Q3 | $0 | Buy |
+2
| New | +$233 | ﹤0.01% | 4357 |
|
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Creative Planning's TNDM Position: Q2 2026 in Review
Creative Planning opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 16,216 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #3736 among its holdings. This is a return to the name: Creative Planning previously reported a position in TNDM as recently as Q4 2025.
Creative Planning first reported a position in TNDM in Q3 2015 and has held it in 29 quarters since. The position peaked at $1.23M in Q2 2019. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Creative Planning held 16,216 shares of Tandem Diabetes Care worth $245K as of Q2 2026.
- Tandem Diabetes Care was a new Creative Planning position in Q2 2026.
- Tandem Diabetes Care made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3736 holding.
- Creative Planning first reported a position in Tandem Diabetes Care in Q3 2015 and has held it in 29 quarters since.
- Creative Planning's Tandem Diabetes Care position peaked at $1.23M in Q2 2019.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.